The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Stoke Therapeutics Inc’s stock clocked out at $13.51, down -5.33% from its previous closing price of $14.27. In other words, the price has decreased by -$5.33 from its previous closing price. On the day, 1.02 million shares were traded. STOK stock price reached its highest trading level at $14.7114 during the session, while it also had its lowest trading level at $13.152.
Ratios:
To gain a deeper understanding of STOK’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.66. For the most recent quarter (mrq), Quick Ratio is recorded 8.41 and its Current Ratio is at 8.41. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on July 18, 2025, initiated with a Buy rating and assigned the stock a target price of $30.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $24.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 01 ’25 when Ticho Barry sold 4,503 shares for $11.63 per share. The transaction valued at 52,379 led to the insider holds 21,279 shares of the business.
BARUCH TICHO bought 9,007 shares of STOK for $102,229 on Jul 01 ’25. On Jun 04 ’25, another insider, Skorpios Trust, who serves as the 10% Owner of the company, sold 3,000,000 shares for $10.20 each. As a result, the insider received 30,600,000 and left with 3,906,181 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STOK now has a Market Capitalization of 737604160 and an Enterprise Value of 384492448. As of this moment, Stoke’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.86 while its Price-to-Book (P/B) ratio in mrq is 2.11. Its current Enterprise Value per Revenue stands at 2.014 whereas that against EBITDA is 9.533.
Stock Price History:
The Beta on a monthly basis for STOK is 1.17, which has changed by -0.14817148 over the last 52 weeks, in comparison to a change of 0.16564083 over the same period for the S&P500. Over the past 52 weeks, STOK has reached a high of $16.15, while it has fallen to a 52-week low of $5.35. The 50-Day Moving Average of the stock is 20.63%, while the 200-Day Moving Average is calculated to be 28.23%.
Shares Statistics:
It appears that STOK traded 671.64K shares on average per day over the past three months and 989050 shares per day over the past ten days. A total of 54.60M shares are outstanding, with a floating share count of 45.85M. Insiders hold about 16.02% of the company’s shares, while institutions hold 98.05% stake in the company. Shares short for STOK as of 1752537600 were 11496684 with a Short Ratio of 17.17, compared to 1749772800 on 12107800. Therefore, it implies a Short% of Shares Outstanding of 11496684 and a Short% of Float of 25.480000000000004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
